Progenitor cells from cartilage--no osteoarthritis-grade-specific differences in stem cell marker expression

Area of Science:

• Tissue Engineering
• Regenerative Medicine
• Osteoarthritis Research

Background:

• Osteoarthritis (OA) necessitates effective cartilage repair strategies.
• Tissue engineering aims to create cartilage substitutes for OA treatment.
• Mesenchymal stromal cells (MSCs) are promising candidates for cartilage regeneration.

Purpose of the Study:

• To analyze the characteristics of MSCs harvested from osteoarthritic cartilage.
• To assess the influence of OA-related damage on MSC properties.
• To evaluate the potential of these cells for cartilage replacement.

Main Methods:

• Harvesting OA cartilage from patients undergoing knee surgery.
• Dissociating cartilage and expanding primary chondrocytes in monolayer culture.
• Monitoring dedifferentiation and analyzing MSC marker expression via flow cytometry.
• Assessing chondrogenesis and osteogenesis potential of expanded cells.

Main Results:

• At third passage, 95% of cells expressed CD105, with most also positive for CD73 and CD90, meeting MSC criteria.
• Dedifferentiated chondrocytes showed coexpression of markers like CD9, CD166, CD90, CD105, CD73, and CD44.
• Cells successfully redifferentiated into sulfated glycosaminoglycan-producing chondrogenic progenitors.
• Osteogenic differentiation did not significantly enhance alkaline phosphatase activity.

Conclusions:

• Chondrogenic progenitors derived from OA cartilage are a viable cellular source for cartilage repair.
• These cells maintain MSC characteristics and chondrogenic potential irrespective of OA severity.
• This finding supports the use of autologous MSCs from OA joints for regenerative therapies.